A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
아직 댓글이 없어요. 가장 먼저 남겨보세요!
Uncommon Therapeutics에 대한 X의 실제 대화
X에 게시
